Nutex Health Inc. $NUTX Shares Acquired by SG Americas Securities LLC

SG Americas Securities LLC lifted its stake in shares of Nutex Health Inc. (NASDAQ:NUTX) by 3,232.6% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 30,360 shares of the company’s stock after acquiring an additional 29,449 shares during the period. SG Americas Securities LLC owned 0.44% of Nutex Health worth $2,885,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Segall Bryant & Hamill LLC acquired a new stake in shares of Nutex Health during the 3rd quarter worth approximately $2,394,000. Topline Capital Management LLC increased its stake in Nutex Health by 80.0% during the third quarter. Topline Capital Management LLC now owns 556,567 shares of the company’s stock worth $57,505,000 after acquiring an additional 247,436 shares during the last quarter. Pertento Partners LLP purchased a new stake in Nutex Health in the third quarter valued at $27,940,000. Hussman Strategic Advisors Inc. purchased a new stake in Nutex Health in the fourth quarter valued at $3,457,000. Finally, JPMorgan Chase & Co. lifted its stake in shares of Nutex Health by 78.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 14,782 shares of the company’s stock valued at $1,527,000 after purchasing an additional 6,476 shares during the last quarter. Institutional investors and hedge funds own 5.32% of the company’s stock.

Nutex Health Stock Performance

Shares of Nutex Health stock opened at $170.89 on Wednesday. The stock has a market capitalization of $1.18 billion, a price-to-earnings ratio of 13.21 and a beta of 0.26. The company has a debt-to-equity ratio of 0.66, a current ratio of 3.14 and a quick ratio of 3.12. The business has a 50-day moving average of $131.86 and a 200 day moving average of $129.94. Nutex Health Inc. has a 12 month low of $77.21 and a 12 month high of $193.07.

Nutex Health (NASDAQ:NUTX) last issued its quarterly earnings results on Thursday, April 30th. The company reported $6.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.99 by $2.53. Nutex Health had a net margin of 10.95% and a return on equity of 23.50%. The company had revenue of $216.49 million for the quarter, compared to analyst estimates of $227.80 million. As a group, sell-side analysts forecast that Nutex Health Inc. will post 22.72 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Lake Street Capital started coverage on shares of Nutex Health in a research note on Tuesday, June 2nd. They set a “buy” rating and a $235.00 target price for the company. B. Riley Financial initiated coverage on shares of Nutex Health in a research note on Friday, June 26th. They issued a “buy” rating and a $290.00 price target on the stock. Wall Street Zen raised shares of Nutex Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. Finally, Weiss Ratings upgraded shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, May 4th. Three equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $243.33.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.